Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 26

1.

Long-term effect of pioglitazone vs glimepiride on lipoprotein oxidation in patients with type 2 diabetes: a prospective randomized study.

Sartore G, Chilelli NC, Seraglia R, Ragazzi E, Marin R, Roverso M, Cosma C, Vaccaro O, Burlina S, Lapolla A.

Acta Diabetol. 2019 May;56(5):505-513. doi: 10.1007/s00592-018-01278-2. Epub 2019 Feb 10.

PMID:
30740640
2.

Impact of a Mediterranean Dietary Pattern and Its Components on Cardiovascular Risk Factors, Glucose Control, and Body Weight in People with Type 2 Diabetes: A Real-Life Study.

Vitale M, Masulli M, Calabrese I, Rivellese AA, Bonora E, Signorini S, Perriello G, Squatrito S, Buzzetti R, Sartore G, Babini AC, Gregori G, Giordano C, Clemente G, Grioni S, Dolce P, Riccardi G, Vaccaro O; TOSCA.IT Study Group.

Nutrients. 2018 Aug 10;10(8). pii: E1067. doi: 10.3390/nu10081067.

3.

Low Glucose Concentrations Induce a Similar Inflammatory Response in Monocytes from Type 2 Diabetic Patients and Healthy Subjects.

Piarulli F, Sartore G, Sechi A, Basso D, Fogar P, Greco E, Ragazzi E, Lapolla A.

Oxid Med Cell Longev. 2017;2017:9185272. doi: 10.1155/2017/9185272. Epub 2017 Oct 31.

4.

Effects on the incidence of cardiovascular events of the addition of pioglitazone versus sulfonylureas in patients with type 2 diabetes inadequately controlled with metformin (TOSCA.IT): a randomised, multicentre trial.

Vaccaro O, Masulli M, Nicolucci A, Bonora E, Del Prato S, Maggioni AP, Rivellese AA, Squatrito S, Giorda CB, Sesti G, Mocarelli P, Lucisano G, Sacco M, Signorini S, Cappellini F, Perriello G, Babini AC, Lapolla A, Gregori G, Giordano C, Corsi L, Buzzetti R, Clemente G, Di Cianni G, Iannarelli R, Cordera R, La Macchia O, Zamboni C, Scaranna C, Boemi M, Iovine C, Lauro D, Leotta S, Dall'Aglio E, Cannarsa E, Tonutti L, Pugliese G, Bossi AC, Anichini R, Dotta F, Di Benedetto A, Citro G, Antenucci D, Ricci L, Giorgino F, Santini C, Gnasso A, De Cosmo S, Zavaroni D, Vedovato M, Consoli A, Calabrese M, di Bartolo P, Fornengo P, Riccardi G; Thiazolidinediones Or Sulfonylureas Cardiovascular Accidents Intervention Trial (TOSCA.IT) study group; Italian Diabetes Society.

Lancet Diabetes Endocrinol. 2017 Nov;5(11):887-897. doi: 10.1016/S2213-8587(17)30317-0. Epub 2017 Sep 13. Erratum in: Lancet Diabetes Endocrinol. 2017 Nov;5(11):e7.

PMID:
28917544
5.

Dietary intake and major food sources of polyphenols in people with type 2 diabetes: The TOSCA.IT Study.

Vitale M, Masulli M, Rivellese AA, Bonora E, Cappellini F, Nicolucci A, Squatrito S, Antenucci D, Barrea A, Bianchi C, Bianchini F, Fontana L, Fornengo P, Giorgino F, Gnasso A, Mannucci E, Mazzotti A, Nappo R, Palena AP, Pata P, Perriello G, Potenziani S, Radin R, Ricci L, Romeo F, Santini C, Scarponi M, Serra R, Timi A, Turco AA, Vedovato M, Zavaroni D, Grioni S, Riccardi G, Vaccaro O; TOSCA.IT Study Group.

Eur J Nutr. 2018 Mar;57(2):679-688. doi: 10.1007/s00394-016-1355-1. Epub 2016 Dec 21.

PMID:
28004268
6.

Curcumin and Boswellia serrata Modulate the Glyco-Oxidative Status and Lipo-Oxidation in Master Athletes.

Chilelli NC, Ragazzi E, Valentini R, Cosma C, Ferraresso S, Lapolla A, Sartore G.

Nutrients. 2016 Nov 21;8(11). pii: E745.

7.

Ketoacidosis in diabetic pregnancy.

Dalfrà MG, Burlina S, Sartore G, Lapolla A.

J Matern Fetal Neonatal Med. 2016 Sep;29(17):2889-95. doi: 10.3109/14767058.2015.1107903. Epub 2015 Nov 23. Review.

PMID:
26461169
8.

Possible role of fructosamine 3-kinase genotyping for the management of diabetic patients.

Avemaria F, Carrera P, Lapolla A, Sartore G, Chilelli NC, Paleari R, Ambrosi A, Ferrari M, Mosca A.

Clin Chem Lab Med. 2015 Aug;53(9):1315-20. doi: 10.1515/cclm-2015-0207.

9.

Correlation between baseline characteristics and clinical outcomes in a large population of diabetes patients treated with liraglutide in a real-world setting in Italy.

Lapolla A, Frison V, Bettio M, Dal Pos M, Rocchini P, Panebianco G, Tadiotto F, Da Tos V, D'Ambrosio M, Marangoni A, Ferrari M, Pianta A, Balzano S, Confortin L, Lamonica M, Marin N, Strazzabosco M, Brun E, Mesturino CA, Simoncini M, Zen F, Bax G, Bonsembiante B, Cardone C, Dal Frà MG, Gallo A, Masin M, Piarulli F, Sartore G, Simioni N.

Clin Ther. 2015 Mar 1;37(3):574-84. doi: 10.1016/j.clinthera.2014.11.015. Epub 2015 Jan 24.

PMID:
25626486
10.

Focusing on potential sources of glucose fluctuations in type 1 and type 2 diabetes: which kind of patient, what kind of glycemic variability and which confounding factors?

Chilelli NC, Sartore G, Lapolla A.

Diabetes Res Clin Pract. 2014 Oct;106(1):e1-2. doi: 10.1016/j.diabres.2014.07.011. Epub 2014 Jul 23. No abstract available.

PMID:
25128267
11.

Mediterranean Diet and Red Yeast Rice Supplementation for the Management of Hyperlipidemia in Statin-Intolerant Patients with or without Type 2 Diabetes.

Sartore G, Burlina S, Ragazzi E, Ferraresso S, Valentini R, Lapolla A.

Evid Based Complement Alternat Med. 2013;2013:743473. doi: 10.1155/2013/743473. Epub 2013 Dec 23. Erratum in: Evid Based Complement Alternat Med. 2014;2014:432141. Giovanni, Sartore [corrected to Sartore, Giovanni]; (4) Silvia, Burlina [corrected to Burlina, Silvia]; Eugenio, Ragazzi [corrected to Ragazzi, Eugenio]; Stefania, Ferraresso [corrected to Ferraresso, Stefania]; Romina, Valentini [corrected to Valentini, R.

12.

Association between glucose variability as assessed by continuous glucose monitoring (CGM) and diabetic retinopathy in type 1 and type 2 diabetes.

Sartore G, Chilelli NC, Burlina S, Lapolla A.

Acta Diabetol. 2013 Jun;50(3):437-42. doi: 10.1007/s00592-013-0459-9. Epub 2013 Feb 16.

PMID:
23417155
13.

An effective and rapid determination by MALDI/TOF/TOF of methionine sulphoxide content of ApoA-I in type 2 diabetic patients.

Seraglia R, Sartore G, Marin R, Burlina S, Manzato E, Ragazzi E, Traldi P, Lapolla A.

J Mass Spectrom. 2013 Jan;48(1):105-10. doi: 10.1002/jms.3113.

PMID:
23303753
14.

Role of endogenous secretory RAGE (esRAGE) in defending against plaque formation induced by oxidative stress in type 2 diabetic patients.

Piarulli F, Lapolla A, Ragazzi E, Susana A, Sechi A, Nollino L, Cosma C, Fedele D, Sartore G.

Atherosclerosis. 2013 Jan;226(1):252-7. doi: 10.1016/j.atherosclerosis.2012.10.050. Epub 2012 Nov 9.

PMID:
23182189
15.

Addition of either pioglitazone or a sulfonylurea in type 2 diabetic patients inadequately controlled with metformin alone: impact on cardiovascular events. A randomized controlled trial.

Vaccaro O, Masulli M, Bonora E, Del Prato S, Giorda CB, Maggioni AP, Mocarelli P, Nicolucci A, Rivellese AA, Squatrito S, Riccardi G; TOSCA.IT study group (Thiazolidinediones Or Sulphonylureas and Cardiovascular Accidents. Intervention Trial).

Nutr Metab Cardiovasc Dis. 2012 Nov;22(11):997-1006. doi: 10.1016/j.numecd.2012.09.003. Epub 2012 Oct 11.

PMID:
23063367
16.

Glyco-oxidation and cardiovascular complications in type 2 diabetes: a clinical update.

Piarulli F, Sartore G, Lapolla A.

Acta Diabetol. 2013 Apr;50(2):101-10. doi: 10.1007/s00592-012-0412-3. Epub 2012 Jul 5. Review.

17.

The importance of HbA1c and glucose variability in patients with type 1 and type 2 diabetes: outcome of continuous glucose monitoring (CGM).

Sartore G, Chilelli NC, Burlina S, Di Stefano P, Piarulli F, Fedele D, Mosca A, Lapolla A.

Acta Diabetol. 2012 Dec;49 Suppl 1:S153-60. doi: 10.1007/s00592-012-0391-4. Epub 2012 Apr 1.

PMID:
22466072
18.

Glucose variability in diabetic pregnancy.

Dalfrà MG, Sartore G, Di Cianni G, Mello G, Lencioni C, Ottanelli S, Sposato J, Valgimigli F, Scuffi C, Scalese M, Lapolla A.

Diabetes Technol Ther. 2011 Aug;13(8):853-9. doi: 10.1089/dia.2010.0145.

PMID:
21751862
19.

Subclinical diastolic dysfunction in type 2 diabetic patients with and without carotid atherosclerosis: relationship with glyco-oxidation, lipid-oxidation and antioxidant status.

Sartore G, Piarulli F, Ragazzi E, Burlina S, Chilelli NC, Sarais C, Marin R, Manzato E, Fedele D, Lapolla A.

Int J Cardiol. 2013 Feb 20;163(2):201-5. doi: 10.1016/j.ijcard.2011.06.026. Epub 2011 Jun 21.

PMID:
21696838
20.

Genetic variability of the fructosamine 3-kinase gene in diabetic patients.

Mosca L, Penco S, Patrosso MC, Marocchi A, Lapolla A, Sartore G, Chilelli NC, Paleari R, Mosca A.

Clin Chem Lab Med. 2011 May;49(5):803-8. doi: 10.1515/CCLM.2011.133. Epub 2011 Feb 3.

PMID:
21288167

Supplemental Content

Loading ...
Support Center